2 results match your criteria: "Guinea-Bissau Research Centre for Vitamins and Vaccines[Affiliation]"
Is early measles vaccination better than later measles vaccination?
Trans R Soc Trop Med Hyg
January 2015
Bandim Health Project, Indepth Network, Apartado 861, Bissau, Guinea-Bissau Research Centre for Vitamins and Vaccines (CVIVA), Bandim Health Project, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark.
WHO recommends delaying measles vaccination (MV) until maternal antibody has waned. However, early MV may improve child survival by reducing mortality from conditions other than measles infection. We tested whether early MV improves child survival compared with later MV.
View Article and Find Full Text PDFMeasles vaccination in the presence or absence of maternal measles antibody: impact on child survival.
Clin Infect Dis
August 2014
Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau Research Centre for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Copenhagen.
Background: Measles vaccine (MV) has a greater effect on child survival when administered in early infancy, when maternal antibody may still be present.
Methods: To test whether MV has a greater effect on overall survival if given in the presence of maternal measles antibody, we reanalyzed data from 2 previously published randomized trials of a 2-dose schedule with MV given at 4-6 months and at 9 months of age. In both trials antibody levels had been measured before early measles vaccination.